9-DEAZAGUANINE DERIVATIVES OR THEIR TAUTOMERS AND PHARMACEUTICAL COMPOSITION SHOWING CAPABILITY TO INHIBIT MAMMAL PURINE NUCLEOSIDE PHOSPHORYLASE ACTIVITY Russian patent published in 1997 - IPC

Abstract RU 2093513 C1

FIELD: organic chemistry, heterocyclic compounds. SUBSTANCE: product: derivatives of 9-deazaguanine of the formula (I): where: CH2-Ar: where: R1 - hydrogen, halogen, / CI- C/ /-alkyl, / CI-C3 /-alkoxy, benzylhydroxy, hydroxy, trifluoromethyl; R2 - hydrogen, halogen, / CI- C3 /-alkoxy, benzylhydroxy, hydroxy, trifluoromethyl under condition: if R2 - hydrogen or / CI- C3 /-alkyl then R1 - trifluoromethyl, or R1 - hydrogen, / CI- C3/-alkyl; if R2 - trifluoromethyl or CH2-Ar - where x - sulfur, oxygen then linkage with thiophene or furan ring is located at 2 or 3 position, or their tautomers. Compounds of the formula (I) were synthesized by interaction of reagent 1 of the formula: where: R3 and R5 - lower alkyl; R4 - carbocyclic aryl, and reagent 2: anhydrous ammonia followed by cyclization and if necessary the protective groups splitting off. Invention relates to also the pharmaceutical composition containing 9-deazaguanine derivative of the formula (I) or its tautomer as an active component taken at amount 0.1-75%, preferably at amount 1-50%, and pharmaceutically acceptable carrier that shows capability to inhibit mammal purine nucleoside phosphorylase activity. EFFECT: improved method of synthesis. 5 tbl

Similar patents RU2093513C1

Title Year Author Number
DERIVATIVES OF AMINO-7-(CHRR)-3H,5H-PYRROLO-[3,2-D]-PYRIMIDINE-4-ONE, METHODS OF THEIR SYNTHESIS AND A METHOD OF SELECTIVE INHIBITION OF MAMMALIAN T-LYMPHOCYTES PROLIFERATION AND NO EFFECTING ON CHRR-LYMPHOCYTES 1992
  • Dzhon A.Sekrist Iii[Us]
  • Mark Dehvid Ehrion[Us]
  • Dzhon A.Montgomeri[Us]
  • Stiven Eh.Ilik[Us]
  • Vejn S.Gajda[Us]
  • Shri Nivas[Us]
RU2097384C1
2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]-DIAZEPINE-6-ONES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION SHOWING INHIBITORY ACTIVITY WITH RESPECT TO HIV-1 REVERSE TRANSCRIPTASE 1995
  • Karl D.Khargrejv
  • Terens A.Kelli
  • Sjuresh R.Kapadija
  • Dzhon R.Praudfut
  • Dehniel' V.Mehknil'
  • Usha R.Patel'
  • Mario Dzh.Kardozo
RU2142464C1
Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER 2010
  • Khotosi Jasumiti
  • Kholland Sasha
  • Pajjan Donal'D Dzh.
RU2555326C2
SUBSTITUTED AMIDES OF THIENOPYRROLECARBOXYLIC ACID, AMIDES OF PYRROLE THIAZOLE CARBOXYLIC ACID AND RELATIVE ANALOGUES AS CASEIN KINASE Iε INHIBITORS 2005
  • Fink Dehvid Mark
  • Chian Jujlin'
  • Kollar Nikola Don
RU2403257C2
PRODRUG 1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES 2003
  • Fobian Ivett M.
  • Freskos Dzhon N.
  • Jagodzinska Barbara
RU2357962C2
BICYCLIC PYRIDINES AND ANALOGUES AS SIRTUIN MODULATORS 2010
  • Ng Pui Ji
  • Blum Charl'Z
  • Makferson Loren
  • Perni Robert B.
  • Vu Chi B.
  • Akhmed Mokhammed Makhmud
  • Dish Dzheremi S.
RU2550821C2
PYRIMIDINE DERIVATIVES WITH ANTAGONIST PROPERTIES TOWARDS CRTH2(VERSIONS) 2004
  • Laj Taj-Vehj
  • Korijama Judzi
  • Josino Takasi
  • Sato Khiroki
  • Tanaka Kazukho
  • Sugimoto Khiromi
  • Manabe Josikhisa
  • Bejkon Kevin
  • Urbans Klaus
  • Seki Masanori
  • Sintani Takuja
RU2361865C2
QUINAZOLINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION 1993
  • Stefen Eh.Vebber
  • Ted M.Blekman
  • Dzhon Ehttard
  • Terens R.Dzhons
  • Majkl D.Varni
RU2135481C1
DERIVATIVES OF PYRROLOPYRIMIDINE, METHOD FOR PREPARING AND THEIR USING 2001
  • Kim Dae-Kee
  • Li Dzu Jang
  • Riu Do Khiun
  • Li Nam Kiu
  • Li Suk Kho
  • Kim Nam-Kho
  • Kim Dzae-Sun
  • Riu Dze Kho
  • Choj Dzin-Jang
  • Im Guang-Dzin
  • Choj Von-Son
  • Kim Tae Kon
  • Cha Khoon
RU2263676C2
METHOD OF SYNTHESIS OF 2'-DEOXY-2'-FLUORORIBONUCLEOSIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1990
  • Sil'Vija Margaret Tisdejl[Gb]
  • Tomas Ehntoni Krenitski[Us]
  • Dzhoehl Van Tattl[Us]
  • Dzhordzh Uolter Kozhalka[Us]
  • Martin Dzhon Slejter[Gb]
  • Susan Meri Deludzh[Us]
  • Vejn Govard Miller[Us]
RU2043361C1

RU 2 093 513 C1

Authors

Dzhon A.Sekrist[Us]

Mark Dehvid Ehrion[Us]

Dzhon A.Montgomeri[Us]

Stiven E.Ilik[Us]

Dates

1997-10-20Published

1991-08-26Filed